scholarly journals Change in renal function post-nephrectomy for renal cell carcinoma in patients with and without hypertension and/or diabetes

2021 ◽  
Vol 58 (2) ◽  
Author(s):  
J John ◽  
M Henry ◽  
A Ringoir ◽  
G Pinto ◽  
K Kesner ◽  
...  
2020 ◽  
Vol 104 (9-10) ◽  
pp. 775-780 ◽  
Author(s):  
Julia Mühlbauer ◽  
Johannes de Gilde ◽  
Michael Mueller-Steinhardt ◽  
Stefan Porubsky ◽  
Margarete Walach ◽  
...  

2021 ◽  
Author(s):  
Yi Mu ◽  
Kehang Chen ◽  
Jun He ◽  
Peng Chen ◽  
Miao Liu ◽  
...  

Abstract Background: To evaluate the application of R.E.N.A.L. nephrometry score (RNS) in laparoscopic partial nephrectomy (LPN) with zero ischemia and sutureless surgery, and to explore the efficacy and safety of zero ischemia and seamless LPN in the treatment of renal cell carcinoma.Methods: The clinical data of 67 patients with renal cell carcinoma treated by LPN in the affiliated Hospital of Guizhou Medical University from January 2016 to July 2020 were analyzed retrospectively. The patients were divided into renal artery occlusion group (n=31) and non-occlusion group (n=36). All cases were divided according to their RNS (low, moderate, and high), and the perioperative condition, postoperative complications, postoperative recovery and changes of renal function in the two groups were analyzed.Results: According to the RNS, all cases were classified in low-complex. Both groups successfully completed the operation without operative complications. Compared with the renal artery occlusion group, the non-occlusion group had a shorter operation time (35.51±20.48 min), shorter hospital stay (6.72±4.39 d), and no significant difference in intraoperative blood loss(50.39±30.19 ml). During the 6-month follow-up, the creatinine value of the renal function in the non-occlusion group (78.47±10.98μmol/L) was lower than that in the occlusion group(98.21±8.06μmol/L).Conclusion: Zero-ischemia sutureless LPN technique can effectively reduce the time of ischemia and avoid renal ischemia-reperfusion injury. This surgical technique may be a feasible surgical method for the treatment of low RNS renal cell carcinoma.


2019 ◽  
Vol 9 (1) ◽  
pp. 48-54 ◽  
Author(s):  
Taisuke Irifuku ◽  
Ayaka Satoh ◽  
Hiroki Tani ◽  
Kouichi Mandai ◽  
Takao Masaki

Abstract Nivolumab is an anti-programmed cell death-1 antibody that is utilized as an immune checkpoint inhibitor for several malignancies. However, this agent is associated with immune-related adverse events (irAEs), mainly in the spectrum of autoimmune disease including interstitial pneumonia, colitis, type 1 diabetes, and renal impairment. We herein present the case of a 59-year-old man with renal cell carcinoma who developed worsening renal function approximately 4 months after initiation of nivolumab. Urinalysis showed proteinuria and microscopic hematuria along with increase levels of N-acetyl-β-d-glucosaminidase. Renal biopsy revealed acute tubulointerstitial nephritis and thickening of the glomerular basement membranes. Immunofluorescence showed granular IgM deposits in capillary loops. We initiated high-dose prednisolone therapy with nivolumab, which improved renal function and achieved complete remission of proteinuria. Although renal irAEs are considered to be rare and glomerulonephropathy is not typical presentation, physicians need the close monitoring of renal function and urinalysis in patients under immunotherapy with this agents. In addition, our case provides a possible link between nivolumab and immune-mediated glomerulonephropathy.


2019 ◽  
Vol 18 (1) ◽  
pp. e1419-e1420
Author(s):  
P. Capogrosso ◽  
A. Larcher ◽  
F. Cianflone ◽  
F. Muttin ◽  
F. Trevisani ◽  
...  

2015 ◽  
Vol 86 (1-2) ◽  
pp. 44-48 ◽  
Author(s):  
Kamran Zargar-Shoshtari ◽  
Kenan Ashouri ◽  
Pranav Sharma ◽  
Adam Baumgarten ◽  
Wade J. Sexton ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document